Gómez-Barrena E, Rosset P, Müller I, Giordano R, Bunu C, Layrolle P, et al. Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med. 2011;15(6):1266–86.

Article  Google Scholar 

Jakob M, Saxer F, Scotti C, Schreiner S, Studer P, Scherberich A, et al. Perspective on the evolution of cell-based bone tissue engineering strategies. Eur Surg Res. 2012;49(1):1–7.

Article  CAS  Google Scholar 

CORDIS. Final report summary - REBORNE (regenerating bone defects using new biomedical engineering approaches). n.d. Retrieved 4 February 2022 from https://cordis.europa.eu/project/rcn/92715/reporting/en.

Fernández RF, Bucchi C, Navarro P, Beltrán V, Borie E. Bone grafts utilized in dentistry: an analysis of patients’ preferences. BMC Med Ethics. 2015;16(1):71.

Article  Google Scholar 

Fernandez de Grado G, Keller L, Idoux-Gillet Y, Wagner Q, Musset AM, Benkirane-Jessel N, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018;9:2041731418776819.

Article  Google Scholar 

Klijn RJ, Meijer GJ, Bronkhorst EM, Jansen JA. A meta-analysis of histomorphometric results and graft healing time of various biomaterials compared to autologous bone used as sinus floor augmentation material in humans. Tissue Eng Part B Rev. 2010;16(5):493–507.

Article  CAS  Google Scholar 

Rosset P, Deschaseaux F, Layrolle P. Cell therapy for bone repair. Orthop Traumatol Surg Res. 2014;100(1 Suppl):S107–12.

Article  CAS  Google Scholar 

Perez JR, Kouroupis D, Li DJ, Best TM, Kaplan L, Correa D. Tissue engineering and cell-based therapies for fractures and bone defects. Front Bioeng Biotechnol. 2018;6:105.

Article  Google Scholar 

James AW, LaChaud G, Shen J, Asatrian G, Nguyen V, Zhang X, et al. A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng Part B Rev. 2016;22(4):284–97.

Article  CAS  Google Scholar 

Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11(6):471–91.

Article  Google Scholar 

Poeran J, Opperer M, Rasul R, Mazumdar M, Girardi FP, Hughes AP, et al. Change in off-label use of bone morphogenetic protein in spine surgery and associations with adverse outcome. Global Spine J. 2016;6(7):650–9.

Article  Google Scholar 

Poon B, Kha T, Tran S, Dass CR. Bone morphogenetic protein-2 and bone therapy: successes and pitfalls. J Pharm Pharmacol. 2016;68(2):139–47.

Article  CAS  Google Scholar 

Ramly EP, Alfonso AR, Kantar RS, Wang MM, Siso JRD, Ibrahim A, et al. Safety and efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2) in craniofacial surgery. Plast Reconstr Surg Glob Open. 2019;7(8):e2347.

Article  Google Scholar 

Grayson WL, Bunnell BA, Martin E, Frazier T, Hung BP, Gimble JM. Stromal cells and stem cells in clinical bone regeneration. Nat Rev Endocrinol. 2015;11(3):140–50.

Article  CAS  Google Scholar 

Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 2014;3:481.

Article  Google Scholar 

Henriksen K, Karsdal MA, Martin TJ. Osteoclast-derived coupling factors in bone remodeling. Calcif Tissue Int. 2014;94(1):88–97.

Article  CAS  Google Scholar 

Teti A. Mechanisms of osteoclast-dependent bone formation. Bonekey Rep. 2013;2:449.

Article  Google Scholar 

Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res. 2007;22(4):487–94.

Article  CAS  Google Scholar 

Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Väänänen HK, Halleen JM. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem. 2004;50(5):883–90.

Article  CAS  Google Scholar 

Bollerslev J, Steiniche T, Melsen F, Mosekilde L. Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types. Bone. 1989;10(1):19–24.

Article  CAS  Google Scholar 

Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet. 2006;43(4):315–25.

Article  Google Scholar 

Horne WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R. Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J Cell Biol. 1992;119(4):1003–13.

Article  CAS  Google Scholar 

Kornak U, Kasper D, Bösl MR, Kaiser E, Schweizer M, Schulz A, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104(2):205–15.

Article  CAS  Google Scholar 

Li CY, Jepsen KJ, Majeska RJ, Zhang J, Ni R, Gelb BD, et al. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res. 2006;21(6):865–75.

Article  CAS  Google Scholar 

Li YP, Chen W, Liang Y, Li E, Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet. 1999;23(4):447–51.

Article  CAS  Google Scholar 

Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest. 2013;123(2):666–81.

CAS  Google Scholar 

Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, et al. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol. 2000;151(2):311–20.

Article  CAS  Google Scholar 

Pennypacker B, Shea M, Liu Q, Masarachia P, Saftig P, Rodan S, et al. Bone density, strength, and formation in adult cathepsin K (-/-) mice. Bone. 2009;44(2):199–207.

Article  CAS  Google Scholar 

Rzeszutek K, Sarraf F, Davies JE. Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth. J Craniofac Surg. 2003;14(3):301–7.

Article  CAS  Google Scholar 

Schaller S, Henriksen K, Sveigaard C, Heegaard AM, Hélix N, Stahlhut M, et al. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res. 2004;19(7):1144–53.

Article  CAS  Google Scholar 

Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 1991;64(4):693–702.

Article  CAS  Google Scholar 

Visentin L, Dodds RA, Valente M, Misiano P, Bradbeer JN, Oneta S, et al. A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J Clin Invest. 2000;106(2):309–18.

Article  CAS  Google Scholar 

Dai XM, Zong XH, Akhter MP, Stanley ER. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res. 2004;19(9):1441–51.

Article  CAS  Google Scholar 

McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354(8):821–31.

Article  CAS  Google Scholar 

Sakagami N, Amizuka N, Li M, Takeuchi K, Hoshino M, Nakamura M, et al. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice. Micron. 2005;36(7–8):688–95.

Article  CAS  Google Scholar 

Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992;360(6406):741–5.

Article  CAS  Google Scholar 

Kreja L, Brenner RE, Tautzenberger A, Liedert A, Friemert B, Ehrnthaller C, et al. Non-resorbing osteoclasts induce migration and osteogenic differentiation of mesenchymal stem cells. J Cell Biochem. 2010;109(2):347–55.

CAS  Google Scholar 

Henriksen K, Andreassen KV, Thudium CS, Gudmann KN, Moscatelli I, Crüger-Hansen CE, et al. A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts. Bone. 2012;51(3):353–61.

Article  CAS  Google Scholar 

Karsdal MA, Neutzsky-Wulff AV, Dziegiel MH, Christiansen C, Henriksen K. Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem Biophys Res Commun. 2008;366(2):483–8.

Article  CAS  Google Scholar 

Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008;105(52):20764–9.

Article  CAS  Google Scholar 

Stessuk T, Husch J, Hermens IAT, Hofmann S, van den Beucken JJJP. Osteogenic differentiation driven by osteoclasts and macrophages. J Immunol Regen Med. 2021;12:100044.

CAS  Google Scholar 

Zhang Y, Chen SE, Shao J, van den Beucken J. Combinatorial surface roughness effects on osteoclastogenesis and osteogenesis. ACS Appl Mater Interfaces. 2018;10(43):36652–63.

Article  CAS  Google Scholar 

Colnot C, Romero DM, Huang S, Helms JA. Mechanisms of action of demineralized bone matrix in the repair of cortical bone defects. Clin Orthop Relat Res. 2005;435:69–78.

Article  Google Scholar 

Davison NL, Gamblin AL, Layrolle P, Yuan H, de Bruijn JD, Barrère-de Groot F. Liposomal clodronate inhibition of osteoclastogenesis and osteoinduction by submicrostructured beta-tricalcium phosphate. Biomaterials. 2014;35(19):5088–97.

Article  CAS  Google Scholar 

Davison NL, Luo X, Schoenmaker T, Everts V, Yuan H, Barrère-de Groot F, et al. Submicron-scale surface architecture of tricalcium phosphate directs osteogenesis in vitro and in vivo. Eur Cell Mater. 2014;27:281–97 (discussion 96-7).

Article